Invex Therapeutics Ltd (ASX:IXC)
Share Price and News


Company Profile:

Invex Therapeutics Ltd (ASX: IXC) a biopharmaceutical company, concentrates on developing effective treatments for neurological conditions, which is caused by raised intracranial pressure (ICP). ICP is considered as a serious issue in a range of neurological conditions, which includes idiopathic intracranial hypertension (IIH), traumatic brain injury or severe stroke. The company was established in March 2019 and is headquartered in Australia.



Code : ASX:IXC Healthcare Company